Related Experiment Video
Updated: Mar 13, 2026

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
Published on: December 19, 2025
Is it Time to Rethink the Use of Steroids for Pulmonary Leptospirosis?
Raajeev V Hingorani1, Rishi Kumar2, Ashit V Hegde3
1Resident Doctor.
High-dose steroids for pulmonary leptospirosis (lung infection) can lead to severe fungal infections. Evidence supporting steroid use is limited, suggesting potential harm outweighs benefits.
Area of Science:
- Infectious Diseases
- Pulmonology
- Mycology
Background:
- Pulmonary involvement is a frequent complication of leptospirosis.
- High-dose corticosteroids are commonly prescribed for pulmonary leptospirosis.
Observation:
- Two cases developed severe invasive fungal infections after steroid treatment for pulmonary leptospirosis.
- These infections occurred despite the standard treatment protocol.
Findings:
- The routine use of steroids in pulmonary leptospirosis may increase the risk of secondary invasive fungal infections.
- The clinical evidence supporting the efficacy of high-dose steroids for this condition is sparse.
Implications:
- Clinicians should carefully weigh the risks and benefits of using high-dose steroids for pulmonary leptospirosis.
- Further research is needed to establish evidence-based treatment guidelines for pulmonary leptospirosis, potentially exploring steroid-sparing alternatives.
More Related Videos
10:32Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
11:36Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Related Concept Videos
Bacterial Phylum Spirochaetes
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...